Norwogonin(CAS: 4443-09-8)

Norwogonin (CAS: 4443-09-8) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), the REACH regulations in the European Union, and FDA/EPA for safety and environmental standards. It is advisable to consult the specific GHS classification for handling and storage instructions.

There are several alternatives to norwogonin (CAS: 4443-09-8) in synthesis, including other flavonoids and isoflavonoids such as wogonin and genistein. These alternatives can serve as effective substitutes depending on the specific application and desired properties.

The market for norwogonin (CAS: 4443-09-8) is growing due to its potential medicinal applications, particularly in cancer research and treatment. Research trends include exploring its anti-inflammatory, antioxidant, and anti-cancer properties. Market demand is expected to increase with further validation of its therapeutic potential.

Waste containing norwogonin (CAS: 4443-09-8) should be collected in appropriate containers and disposed of according to local hazardous waste regulations. Incineration is one method, but professional waste disposal services are recommended to ensure environmental safety and compliance with regulatory standards.